Notice of NIAMS's Participation in PA-16-240 "Mechanisms Mediating Osteoarthritis in Aging (R21)"

Notice Number: NOT-AR-17-007

Key Dates
Release Date:   May 16, 2016

Related Announcements
PA-16-240

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

This Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate in the Funding Opportunity Announcement (FOA) PA-16-240 "Mechanisms Mediating Osteoarthritis in Aging (R21)". However, it is not the intent of NIAMS to support clinical trials through this FOA. Applicants who wish to submit clinical trials applications to the NIAMS are encouraged to utilize one of the NIAMS FOAs listed in "Policies and Guidelines for Investigator-Initiated Clinical Trials" on the NIAMS website.

The following sections have been updated to reflect the participation of NIAMS in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.886; 93.846

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Bernadette Tyree, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5505
Email: tyreeb@mail.nih.gov

Financial/Grants Management Contact(s)

Melinda Nelson
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-435-5278
Email: nelsonm@mail.nih.gov  

Peer Review Contact(s)

Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Bernadette Tyree, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5505
Email: tyreeb@mail.nih.gov